Download full-text PDF

Source
http://dx.doi.org/10.7205/MILMED-D-16-00181DOI Listing

Publication Analysis

Top Keywords

era partnership
4
partnership uniformed
4
uniformed services
4
services university
4
university armed
4
armed forced
4
forced medical
4
medical college
4
college pune
4
pune india
4

Similar Publications

Woven Cement Slurry.

Adv Mater

January 2025

College of Civil Engineering and Architecture, Zhejiang University, Hangzhou, 310058, China.

Weaving, a pivotal technique in human construction activities since the Neolithic era, remains unattainable in modern concrete construction. Here, a novel particle-polymer coalescence strategy is proposed, which involves electrostatic, bridging, coordinating, and hydrogen bonding interactions, to establish balanced particle cohesion, enabling the fabrication of stretchable cement slurry. The bending, knotting, coiling, winding, and interlacing of cement filaments for structural textiles is successfully realized beyond traditional formwork casting, grouting, and 3D-printing, and fabricate the first-ever Chinese knot woven with cement.

View Article and Find Full Text PDF

Cerebral Microbleeds and Amyloid Pathology Estimates From the Amyloid Biomarker Study.

JAMA Netw Open

January 2025

Alzheimer Center Limburg, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.

Importance: Baseline cerebral microbleeds (CMBs) and APOE ε4 allele copy number are important risk factors for amyloid-related imaging abnormalities in patients with Alzheimer disease (AD) receiving therapies to lower amyloid-β plaque levels.

Objective: To provide prevalence estimates of any, no more than 4, or fewer than 2 CMBs in association with amyloid status, APOE ε4 copy number, and age.

Design, Setting, And Participants: This cross-sectional study used data included in the Amyloid Biomarker Study data pooling initiative (January 1, 2012, to the present [data collection is ongoing]).

View Article and Find Full Text PDF

Background: Transcriptomics biomarkers have been widely used to predict mortality in patients with sepsis. However, the association between mRNA levels and outcomes shows substantial variability over the course of sepsis, limiting their predictive performance. We aimed to: (a) identify and validate an mRNA biomarker signature whose association with all-cause intensive care unit (ICU) mortality is consistent at several timepoints; and (b) evaluate how this mRNA signature could be used in association with lactate levels for predictive and prognostic enrichment in sepsis.

View Article and Find Full Text PDF

Objective: To evaluate the impact of ART duration and CD4 count on risk for high grade cervical dysplasia in women with HIV (WWH) compared to women without HIV in the treat-all era with integrase strand inhibitors (INSTIs).

Design: Prospective longitudinal cohort study in Botswana.

Methods: From February 2021 to August 2022, baseline HPV self-sampling was offered to women with and without HIV.

View Article and Find Full Text PDF

SARS-COV-2 Pre-Exposure Prophylaxis With Tixagevimab-Cilgavimab in Haematological, Immunocompromised Patients in the Omicron Era.

Eur J Haematol

January 2025

Department of Haematology, Oncology, Immunology, Palliative Medicine, Infectious Diseases and Tropical Medicine, Muenchen Klinik Schwabing, Munich, Germany.

Article Synopsis
  • Tixagevimab-cilgavimab is effective in reducing severe COVID-19 outcomes in high-risk hematological malignancy patients during the Omicron wave, despite a significant incidence of breakthrough infections.
  • 32.6% of patients experienced COVID-19 infections, but most cases were milder and shorter in duration, especially within the first six months of treatment.
  • Recent B-cell depletion was identified as a significant risk factor for breakthrough infections, indicating that these patients may need extra caution and monitoring.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!